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Introduction
MELAS, a syndrome characterized by myopathy,
encephalopathy, lactic acidosis and stroke-like episodes, has
been related to an alteration in mitochondrial DNA
(mtDNA). Mitochondria are intracellular organelles which
are the sites of the oxidative phases of cell respiration [1].
Mitochondria have their own DNA. In most eukaryotes,
mtDNA exists as a double-stranded, closed circle which has
the capability to replicate. Mitochondrial genes have been
identified to code 13 proteins that are essential to the cellu-
lar respiratory functions of the mitochondria [2]. Protein
encoded by intra-organelle genes act, along with proteins of
nuclear origin, to guarantee the respiratory function of the
mitochondria. Because cellular respiration is such an intri-
cate metabolic process, disruption of any mitochondrial or
nuclear gene by mutation is likely to have impact on that
organism. mtDNA is particular vulnerable to mutations [3].
The inheritance of mitochondria-related diseases is more
complex than that of diseases due to genetic alterations of
the nucleus. A zygote receives a large number of organelles
through the egg. Only few of them contain a mutation.
During the early phases of life, cell division disperses the
initial population of the mitochondria and new populations
of the organelles are reproduced by the original. Therefore,
if a mutation is present in some of the initial populations of
mitochondria, the adult cell will have a variety of
organelles, both normal and abnormal. This condition is
called heteroplasmy [4]. 
Human disorders that are attributable to mutations of the
mtDNA have to meet several criteria. They can be either
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Abstract Many findings relate
migraine and cluster headaches to a
genetic alteration, even if the site of
the defect has not been identified.
Some of these findings indicate an
involvement of mitochondrial DNA,
although some contrasting results
have been reported. We describe a
case of cluster headache occurring in
a patient with MELAS syndrome.
The diagnosis of MELAS was sup-
ported by the familiar anamnesis (the
mother suffered from a similar
form), by the laboratory reports
(lacto-acidosis), by instrumental
analysis (signs of encephalopathy on
magnetic resonance imaging) and by
biopsy findings (myopathy). The
diagnosis was confirmed when a
point mutation (Leu mutation at
position 3423 of mitochondrial
RNA) was found in the mitochondri-
al gene. The recurrent periods, char-
acterized by attacks of unilateral pain
and accompanied by homolateral
symptoms (e.g. tearing, palpebral
ptosis, rhinorrea), did not leave any
doubt as to the diagnosis of cluster
headache. We discuss whether the
co-existence of MELAS and cluster
headache was coincidental or causal. 
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sporadic, when mutations occur in somatic cells, or inherit-
ed when the gene alteration is present in oocytic organelles.
Inheritance must exhibit a maternal rather than a mendelian
pattern. The mtDNA alteration must produce a deficit in the
bio-energetic function of the organelle [5]. On the other
hand, a disruption of mitochondrial function could also arise
from a nuclear gene alteration. Mitochondrial disorders can
be categorized as due to: primary mutations of DNA, either
sporadic or maternally inherited; nuclear mutations which
provoke either direct alterations in mtDNA or intergenomic
signalling defects; mendelian defects that affect the respira-
tory chain in the absence of mtDNA mutations. The differ-
ence (if one exists) in the pathophysiology of these three
possibilities has not been determined [6].
MELAS is one of the major mitochondria-related
encephalomyopathies. MELAS has been related to a point
mutation resulting in the presence of leucine in position
3234 of mitochondrial tRNA [7].
MELAS has been related to migraine, in as much as the
symptomatology is often characterized by migraine-like
attacks (i.e. headache with nausea and vomiting). The rela-
tionship between MELAS and migraine-like attacks and
the consideration that migraine could have a familiar
inheritance with a preferential maternal line have suggest-
ed possible common elements at the basis of the two clin-
ical entities [8]. One study showed that there was a high
frequency of mitochondrial gene alterations (same Leu
mutation) in a population of migraine patients [9]. These
findings were not confirmed by a subsequent investigation
[10], nor was an alteration in mtRNA found in cluster
headache patients [11]. On the other hand Montagna [12]
demonstrated, with spectroscopy resonance, an alteration
of the neuronal cell respiratory function in cluster
headache patients, while Montagna et al. [13] described a
case of cluster headache with an extensive deletion of the
mitochondrial genome. These findings support the hypoth-
esis of the hereditability of migraine and cluster headache.
We described a case of a typical cluster headache feature in
a subject with MELAS.
Case report
A 37-year-old man came to our observation at the headache
centre of Rome. He reported episodes of headache which
occurred over a period of about 2 months. These periods re-
occurred with a frequency of twice a year for 7 years.
During these periods the occurrence of the headache attacks
had an impressive chronological pattern: the attacks
occurred every day at 1:00 a.m. and 4:00 p.m. Each attack
lasted about 45 minutes. The pain was localized in the left
side, involved the orbit and the facial and parietal regions,
and spread to the maxillary area. Pain was described as
excruciatingly sharp. Accompanying symptoms usually
described for cluster headache occurred, along with other
(stroke-like) symptoms not usually associated. In particular,
conjunctival hyperemia, tearing, palpebral ptosis, and nasal
obstruction were always present on the same side as the
pain. These episodes matched the diagnostic crteria outlined
by the Ad Hoc Committee of the International Headache
Society (IHS). In addition, hemiplegia, aphasia, and blind-
ness often occurred during the crises, and disappeared at the
end of the attacks. He reported that his mother suffered from
an analogous form, with cluster headache-like attacks (even
if the pain intensity was described as significantly lighter)
accompanied by the same stroke-like symptoms (hemiple-
gia, aphasia, amaurosis). It was not possible to evaluate if
other analogous cases occurred in his pedigree
The personal anamnesis showed that before the occur-
rence of the cluster period, the patient had suffered from
stroke-like attacks that had the same duration as that of the
accompanying headache. The chronological pattern of
these pre-cluster episodes was not determined, occurring
5–6 times during a year. No other important pathologies
were referred. The stroke-like attacks which occurred
before the onset of the cluster headache-like disease were
similar to those present during the headache attacks. The
patient referred transitory (5–10 min) episodes of amauro-
sis, with loss of coordination, hemiplegia and, sometimes,
aphasia. 
The general clinical investigation revealed a light
hypotrophy of the muscles with relative weakness.
Neurological examination was normal. Neuroimaging tech-
niques documented the presence of encephalopathy, partic-
ularly at the posterior level (Fig. 1). No lesions were found
in the hypothalamus. Electromyographic examination
demonstrated the myopathic alteration. Laboratory investi-
gation did not reveal any abnormal values. A significant
increase of lactic acid in the blood was found during the
attacks. The basal values were 15 mg/dl 2 hours after the
crisis. They increased to 80–110 mg/dl during the crisis,
and descended to 20 mg/dl at the end of the crisis
Electrocardiographic features were not altered. A muscular
biopsy was carried out in order to examine the mtDNA
along with the leucocytic mtDNA. The polymerase chain
reaction (PCR) technique was applied to sequence the
DNA. A point mutation was found (cytosine to thymine).
The mutation was related to the Leu alteration in the tRNA
at position 3243. 
The last cluster headache-like period was treated with
verapamil (oral dose of 80 mg, 3 times a day), which
appeared to shorten the length of the florid phase (40 days).
The attacks were treated with oxygen, which only partially
(30% as reported by the patient) attenuated the intensity of
the attack, whereas the duration was unaffected.
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Discussion
We described a patient with typical cluster headache
attacks co-existing with stroke-like symptomatology. The
attacks were also characterized by an increase in lactic acid
well above the normal level. The instrumental investiga-
tion indicated the presence of encephalopathy and myopa-
thy. The patient’s mother was affected by an analogous
form of headache. The presence of a point mutation in the
mtDNA confirmed the diagnosis of MELAS, with a possi-
ble maternal inheritance. MELAS is often characterized by
migraine-like attacks, and this had encouraged studies on
the possible involvement of mtDNA in migraine. The only
study which described an elevated frequency of mitochon-
drial alterations was not confirmed by others which have
followed. A survey carried out on cluster headache patients
showed that their mtDNA was normal. Thus, an alteration
of mtDNA in the common pathogenesis of migraine and
cluster headache was excluded. On the other hand, evi-
dence that the syndromes characterized by altered mtDNA
could sometimes show migraine or cluster headache-like
characteristics indicates that a dysfunction of the mito-
chondria could contribute to the headache attacks. Our
case is significant in this sense, as it occurred in a patient
who has features of MELAS syndrome with typical cluster
headache attacks. The high blood level of lactic acid
observed only during the headache attacks is suggestive of
an involvement of acidosis in the genesis of cluster
headache. Acidosis could participate in the pathogenesis of
cluster headache at either a peripheral or central level.
Peripherally, a decrease in pH could stimulate the nocicep-
tive fibers that are putatively involved in genesis the clus-
ter headache attacks. The proton (H+) is a potent activating
stimulus of nocicpetive fibers. On the other hand, meta-
bolic acidosis could interfere with central nervous system
function, in this case by evidentiating a hypothetical alter-
ation of some central structures.
Fig. 1 MR image showing an ischemic-like lesion at the cerebellar
level (arrow)
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